Jefferies Financial Group Inc. acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor acquired 40,401 shares of the company’s stock, valued at approximately $560,000.
A number of other institutional investors and hedge funds have also made changes to their positions in SGRY. Swiss National Bank increased its holdings in shares of Surgery Partners by 1.1% during the 1st quarter. Swiss National Bank now owns 153,500 shares of the company’s stock worth $1,830,000 after buying an additional 1,700 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Surgery Partners by 239.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after buying an additional 2,051 shares during the period. Public Employees Retirement System of Ohio acquired a new position in Surgery Partners in the second quarter valued at $38,000. Fifth Third Bancorp boosted its holdings in Surgery Partners by 5,324.0% in the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after acquiring an additional 3,993 shares during the last quarter. Finally, Inspire Investing LLC boosted its holdings in Surgery Partners by 10.1% in the third quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock valued at $621,000 after acquiring an additional 4,099 shares during the last quarter.
Surgery Partners Price Performance
Surgery Partners stock opened at $26.95 on Monday. Surgery Partners, Inc. has a 52-week low of $11.41 and a 52-week high of $27.23. The firm has a fifty day moving average of $17.30 and a 200-day moving average of $15.10. The firm has a market capitalization of $3.53 billion, a P/E ratio of -39.63 and a beta of 1.85. The company has a quick ratio of 2.01, a current ratio of 2.17 and a debt-to-equity ratio of 1.03.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its earnings results on Monday, November 9th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Surgery Partners had a negative net margin of 2.59% and a positive return on equity of 0.98%. The business had revenue of $815.30 million for the quarter, compared to the consensus estimate of $820.96 million. During the same quarter last year, the firm posted $0.13 EPS. The business’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, analysts predict that Surgery Partners, Inc. will post 0.07 EPS for the current year.
Insiders Place Their Bets
In other Surgery Partners news, Director Teresa DeLuca purchased 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, with a total value of $143,500.00. Following the transaction, the director owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 2.00% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the company. Raymond James Financial set a $23.50 price target on Surgery Partners in a research report on Monday, October 26th. Zacks Research downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. UBS Group lowered Surgery Partners from a “buy” rating to a “hold” rating and lifted their price objective for the company from $21.00 to $23.50 in a research note on Wednesday, October 28th. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Finally, Stonex Financial cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $20.70.
View Our Latest Analysis on SGRY
Surgery Partners Company Profile
Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.
See Also
- Five stocks we like better than Surgery Partners
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
